Variables | Postoperative adjuvant chemotherapy | X2 | P | |
---|---|---|---|---|
Absence (n = 84) | Presence(n = 64) | |||
Gender | ||||
male | 43 | 40 | ||
female | 41 | 24 | 1.886 | 0.170 |
Age (years) | ||||
< =55 | 19 | 22 | ||
> 55 | 65 | 42 | 2.507 | 0.113 |
Tumor differentiation | ||||
low | 18 | 5 | ||
moderate | 61 | 56 | ||
high | 5 | 3 | 5.458 | 0.065 |
Tumor size (cm) | ||||
> 5 cm | 37 | 24 | ||
< =5 cm | 47 | 40 | 0.643 | 0.423 |
Microvascular.invasion | ||||
absence | 60 | 43 | ||
presence | 24 | 21 | 0.309 | 0.578 |
Nerve invasion | ||||
absence | 68 | 56 | ||
presence | 16 | 8 | 1.146 | 0.284 |
Preoperative Ca19–9(u/ml) | ||||
≤ 37.00u/ml | 37 | 27 | ||
> 37.00u/ml | 47 | 37 | 0.051 | 0.821 |
Preoperative TBIL (umol/L) | ||||
≤ 17.1 umol/L | 71 | 59 | ||
> 17.1 umol/L | 13 | 5 | 1.997 | 0.158 |
HbsAg | ||||
positive | 48 | 33 | ||
negative | 36 | 31 | 0.457 | 0.499 |
Surgical type | ||||
Open surgery | 61 | 44 | ||
laparoscopic surgery | 23 | 20 | 0.264 | 0.608 |
Type of liver resection | ||||
local liver resection | 25 | 26 | ||
left lateral lobe resection | 17 | 14 | ||
left hemihepatectomy | 16 | 9 | ||
right hemihepatectomy | 11 | 9 | ||
Other types of liver resection | 15 | 6 | 3.692 | .449 |
Postoperative molecular targeted drug | ||||
absence | 67 | 49 | ||
presence | 17 | 15 | 0.219 | 0.639 |